Aptevo therapeutics inc. (APVO)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Dec'15
ASSETS
Current assets:
Cash and cash equivalents

12,258

12,448

17,683

20,957

37,011

30,635

28,447

7,228

11,830

7,095

75,830

22,269

14,014

9,676

10,894

5,496

4,637

Short-term investments

-

-

-

-

-

-

-

-

-

73,688

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

9,192

37,503

49,824

-

20,946

25,958

46,877

44,849

49,785

-

-

Accounts receivable

-

-

7,918

7,378

5,801

5,220

6,202

6,145

3,098

2,141

528

4,715

1,926

307

2,958

8,514

6,456

Inventories

-

-

7,482

6,967

4,346

1,785

3,969

2,970

1,285

1,028

1,237

7,984

8,063

461

11,574

20,130

20,322

Prepaid expenses

1,343

1,078

2,215

5,200

6,923

6,907

5,195

4,863

4,093

4,022

-

-

-

-

-

-

-

Held for sale assets - current

-

16,309

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

10,155

-

-

-

Restricted cash, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

400

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

3,540

-

-

-

Other current assets

1,224

160

1,491

3,170

3,561

4,142

6,990

7,138

6,630

6,710

-

-

-

2,026

-

-

-

Restricted cash

-

-

-

-

-

-

-

400

400

-

10,400

400

400

-

400

400

-

Income tax receivable, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,399

1,376

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

6,381

5,867

6,116

-

3,818

3,908

2,343

Total current assets

14,825

29,995

36,789

43,672

57,642

48,689

60,395

66,247

77,160

95,084

115,322

67,193

77,396

71,414

79,429

39,847

35,134

Restricted cash

-

-

-

7,498

7,448

-

400

-

-

400

-

-

-

-

-

-

-

Restricted cash

2,529

7,498

7,498

-

-

7,448

7,448

-

-

10,000

-

-

-

-

-

-

-

Restricted cash, net of current portion

-

-

-

-

-

-

-

12,447

11,243

-

-

-

-

-

-

-

-

Property and equipment, net

3,629

3,946

4,271

4,610

4,978

5,202

5,608

5,638

5,936

5,843

6,163

6,205

6,384

5,910

6,139

6,342

4,179

Intangible assets, net

-

-

4,628

4,835

5,043

5,250

5,458

5,665

5,873

6,080

6,287

13,493

14,013

6,910

-

-

-

Operating lease right-of-use asset

3,504

3,747

3,981

4,264

4,481

-

-

-

-

-

-

-

-

-

-

-

-

Held for sale assets - non-current

-

7,465

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

7,624

-

-

-

Other assets

757

757

3,389

1,248

1,249

905

25

-

-

-

3,250

-

-

-

-

-

-

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,800

41,800

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,055

16,268

17,441

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,902

29,213

Total assets

25,244

53,408

60,556

66,127

80,841

67,494

78,934

89,997

100,212

117,007

131,022

86,891

97,793

91,858

100,623

118,159

127,767

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and other accrued liabilities

5,001

6,427

-

-

-

11,671

9,808

9,535

7,263

7,350

7,512

5,349

8,766

10,518

8,951

-

10,084

Accounts payable

-

-

12,073

11,904

11,043

-

-

-

-

-

-

-

-

-

-

11,192

-

Accrued compensation

1,085

2,870

3,483

2,535

5,042

3,898

3,875

2,685

2,146

4,626

3,815

2,944

2,505

4,009

3,429

2,739

3,334

Sales rebates and discounts payable

-

-

868

894

857

1,245

936

-

-

623

-

-

-

-

-

-

-

Loan payable, net

-

-

19,707

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales rebates and discounts payable

-

-

-

-

-

-

-

953

835

-

-

-

-

-

-

-

-

Contingent consideration, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

183

191

444

Sales rebates and discounts

-

-

-

-

-

-

-

-

-

-

378

2,146

2,310

-

-

-

2,238

Due to acquirer of discontinued operations

-

-

-

-

-

-

-

-

-

-

878

-

-

-

-

-

-

Provisions for chargebacks

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,030

2,512

-

Deferred revenue, current portion

-

-

-

-

-

-

-

-

-

-

-

1,444

878

811

640

394

3,843

Current portion of long-term debt

-

19,863

-

-

-

-

-

4,167

5,333

3,333

-

-

-

-

-

-

-

Held for sale liabilities - current

-

8,135

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

907

944

1,121

1,265

1,348

796

823

762

1,696

2,578

2,287

-

-

278

-

-

-

Current liabilities held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

3,928

-

-

-

Total current liabilities

6,993

38,239

37,252

16,598

18,290

17,610

15,442

18,102

17,273

18,510

14,870

11,883

14,459

19,544

15,233

17,028

19,943

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

2,796

2,802

2,896

3,096

3,340

3,318

Long-term debt, net

-

-

-

19,558

19,415

19,278

19,143

15,400

13,975

15,728

17,484

18,745

18,435

18,383

18,111

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

506

15,817

Other liabilities

-

-

12

13

11

200

349

465

600

734

8,358

2,047

611

469

433

88

71

Operating lease liability

3,099

3,327

3,547

3,759

3,995

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

10,092

41,566

40,811

39,928

41,711

37,088

34,934

33,967

31,848

34,972

40,712

35,471

36,307

41,292

36,873

20,962

39,149

Stockholders' equity:
Preferred stock: $0.001 par value; 15,000,000 shares authorized, zero shares issued or outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

-

0

Common stock: $0.001 par value; 500,000,000 shares authorized; 3,232,811 and 3,234,232 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

45

45

45

45

45

23

23

23

22

22

21

21

21

20

20

-

-

Additional paid-in capital

180,066

179,653

179,382

178,912

178,511

157,791

157,258

156,760

155,998

155,837

154,257

153,239

152,143

151,271

149,493

-

-

Accumulated other comprehensive loss

-

-

-

-

-

-

-2

-36

-83

-105

-10

-14

-41

-33

-17

-

-

Contribution receivable from former parent

-

-

-

-

-

-

-

-

-

-

-

-

-

20,000

20,000

-

-

Former parent investment in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

320,606

Parent investment in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

354,913

-

Accumulated deficit

-164,959

-167,856

-159,682

-152,758

-139,426

-127,408

-113,279

-100,717

-87,573

-73,719

-63,958

-101,826

-90,637

-80,692

-65,746

-257,716

-231,988

Total stockholders' equity

15,152

11,842

19,745

26,199

39,130

30,406

44,000

56,030

68,364

82,035

90,310

51,420

61,486

50,566

63,750

97,197

88,618

Total liabilities and stockholders' equity

25,244

53,408

60,556

66,127

80,841

67,494

78,934

89,997

100,212

117,007

131,022

86,891

97,793

91,858

100,623

118,159

127,767